Upjohn Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Kalamazoo MI United States (1886)
Status: Acquired by Pharmacia & Upjohn (1995) → now Pfizer (2003)

Organization Overview

First Clinical Trial
1998
NCT00005626
First Marketed Drug
1946
streptomycin (kabikinase)
First NDA Approval
1946
streptomycin (kabikinase)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

UPJOHN | UpJohn US 1 LLC

Active Ingredients

Marketed Drugs (32)

alprazolam (xanax) (1981 NDA)

alprostadil (prostin) (1981 NDA)

amlodipine (norvasc) (1992)

atorvastatin (lipitor) (1996)

azacitidine (vidaza) (1971)

benzphetamine (didrex) (1960 NDA)

cefpodoxime (vantin) (1992 NDA)

celecoxib (celebrex) (1998)

chlorphenesin (maolate) (1965 NDA)

dinoprostone (prostin e2) (1977 NDA)

doxazosin (cardura) (1990)

eletriptan (relpax) (2002)

eplerenone (inspra) (2002)

fluoxymesterone (NDA)

gabapentin (neurontin) (1993)

glyburide (micronase) (1984 NDA)

hydrocortisone (solu-cortef) (NDA)

ibuprofen (motrin) (1974 NDA)

latanoprost (xalatan) (1996)

methylscopolamine bromide (NDA)

minoxidil (loniten) (NDA)

nitroglycerin (transderm-nitro) (2000)

novobiocin (albamycin) (1964 NDA)

phenytoin (mesantoin) (1953)

pregabalin (lyrica) (2004)

sertraline (zoloft) (1991)

sildenafil (viagra) (1998)

streptomycin (kabikinase) (1946 NDA)

tolterodine (detrol) (1998)

uracil mustard (NDA)

venlafaxine (effexor) (1997)

ziprasidone (geodon) (2001)

Drugs in Phase 4 Trials (2)

oxycodone (oxycontin) (1 trial)

pregabalin (lyrica) (1 trial)

Drugs in Phase 3 Trials (1)

methylprednisolone (medrol) (1 trial)

Drugs in Phase 2 Trials (7)

cytarabine (cytosar-u) (1 trial)

didanosine (videx) (3 trials)

irinotecan (Camptosar) (1 trial)

prednisone (meticorten) (1 trial)

sargramostim (leukine) (1 trial)

zalcitabine (hivid) (2 trials)

zidovudine (retrovir) (4 trials)

Drugs in Phase 1 Trials (2)

alvircept sudotox (1 trial)

atevirdine (2 trials)

Drugs in Other Trials (3)

clindamycin (cleocin) (1 trial)

leucovorin (1 trial)

pyrimethamine (daraprim) (1 trial)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 15